We're really excited and proud in British Columbia with the self-screening. As you can imagine, it helps to reduce the barriers of tremendous geographic distance, history of trauma, those who have traditionally not been within the screening system, and the disproportionate number of minorities not getting screened. All of these opportunities are there, and it has been embraced incredibly well—even by people who have not yet entered the screening age group—with regard to how approachable and surmountable it seems now.
I think we're getting there in some other disease states as well. I'm proud to say that we have free testing for molecular classification in Canada and, again, some of the other initiatives we talked about, so we are feeling that there's empowerment in a community eight hours from Vancouver to try to do these things. We have molecular stratification in other cancers that are underfunded, like vulvar cancer 2, where we're getting to tools with more precision.
I think we can get there. I think we just have to make sure that it's across the whole country and that there is enthusiasm as well as and education for the value added.